2/2/2025
ASHVA is a pioneering health-tech company dedicated to muscle and skeletal health. The company has developed Fitknees, an AI-powered wearable sensor system designed to enhance post-operative knee recovery. The device is prescribed by orthopedic surgeons and utilized by physiotherapists to assess the root cause of knee issues in just 10 minutes.
Fitknees is a clinically validated, ISO-certified, and globally patented technology available in 150+ hospitals and physiotherapy centers. It provides patients with detailed data analytics reports on their knee health.
📌 MRP of Fitknees + Fitmust Combo: ₹7.5 Lakhs + GST
The founder pitched for ₹50 Lakhs for 1.25% equity, valuing the company at ₹40 Crores.
📌 Devices Sold in FY 2024-25 (Till Nov): 16 Fitknees + Fitmust combos
💰 Total Amount Raised So Far: ₹4.85 Crores
🚫 Peyush Bansal: Opted out, citing high product cost & early-stage challenges.
🚫 Anupam Mittal: Did not see a clear product roadmap.
🚫 Namita Thapar: Product is expensive, and valuation is too high.
🚫 Kunal Bahl: Chose to step out.
✅ Vineeta Singh: Made a founder bet and initially offered ₹50 Lakhs for 4% equity (Valuation: ₹12.5 Cr).
✍️ Final Deal: ₹50 Lakhs for 2.7% Equity + 1.3% Advisory Equity - Founder Accepted!
ASHVA is making significant strides in AI-powered knee rehabilitation. With strong hospital partnerships and clinically validated technology, the company is set to disrupt the orthopedic health-tech space. With Vineeta Singh on board, ASHVA is positioned for scaling and strategic expansion. 🚀